This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Steve Todryk, Ph.D.

Chief Scientific Officer, CTL Europe

Personal Statement

I have over 30 years’ experience working in academic environments on cellular immunology, with a focus on T cell and B cell responses in the context of infections, vaccines, allergy, autoimmunity, cancer, and transplantation. The monitoring of the underlying immune responses, using powerful technologies such as Immunospot®, can provide informative biomarkers as well as give insights into key immunological mechanisms. As the Chief Scientific Officer of CTL Europe, I provide scientific leadership, support and liaisons for our European customers, as well as opportunities for collaborative academic research and for contract research. I advocate our belief that ImmunoSpot® is within everyone’s reach.

Education and Training
  • BSc (hons) Biology, Aston University, Birmingham, UK
  • PhD University of London, UK
  • Postdoctoral positions in London, Dublin (Trinity, Ireland) and Oxford UK (Jenner Institute)
  • Academic positions (Assistant and Associate Professor) in Dublin and in Newcastle, UK
  • Professor of Immunology, Northumbria University, Newcastle upon Tyne, UK; since 2012
Steve
Peer-reviewed Publications (Google Scholar: h-index 40, 97 publications, 6,900 citations): Steven Todryk- Google Scholar
  1. Todryk SM, Bassendine MF, Bridge SH. Revisiting the Elusive Hepatitis C Vaccine. Vaccines. 2021;9(2):114
  2. Hasan SF, Jozwik A, Heaps A, Kakkar N, Donnelly I, Cookson S, Bourke SJ, McSharry C, Todryk SM. Antibody and T cell responses against avian and microbial antigens associate with hypersensitivity pneumonitis disease parameters in pigeon breeders. Allergy. 2020;75:1469-1473
  3. Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation. Ottaviano G, Chiesa R, Feuchtinger T, Vickers MA, Dickinson A, Gennery AR, Veys P, Todryk S. Cells. 2019;8:47
  4. Todryk S, Jozwik A, de Havilland J, Hester J. Emerging Cellular Therapies: T Cells and Beyond. Cells. 2019;8(3):284
  5. Todryk SM. T Cell Memory to Vaccination. Vaccines. 2018;6(4):84
  6. Jaat FG, Hasan SF, Perry A, Cookson S, Murali S, Perry JD, Lanyon CV, De Soyza A, Todryk SM. Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease. Respir Res. 2018;19(1):106.